Press Releases
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
May 23, 2018
NEW YORK--(BUSINESS WIRE)-- PAVmed Inc. (Nasdaq: PAVM, PAVMZ) (the “Company”), a highly differentiated, multiproduct medical device company, previously announced on May 8, 2018 that the...
-
May 22, 2018Conference call to be held May 30, 2018 at 4:30 p.m. Eastern time
NEW YORK--(BUSINESS WIRE)-- PAVmed Inc. (Nasdaq: PAVM, PAVMZ) (the “Company” or “PAVmed”), a highly differentiated, multiproduct medical device company, today reports financial results for...
-
May 18, 2018
NEW YORK--(BUSINESS WIRE)-- PAVmed Inc. (Nasdaq: PAVM, PAVMZ) (the “Company”), a highly differentiated, multiproduct medical device company, today announced that the Company will host a...
-
May 15, 2018
NEW YORK--(BUSINESS WIRE)-- PAVmed Inc. (Nasdaq: PAVM, PAVMW)) (“PAVmed”), a highly differentiated, multiproduct medical device company, announced today that its board of directors approved a...
-
May 14, 2018PAVmed subsidiary Lucid Diagnostics Inc. secures exclusive worldwide license for EsoCheck
NEW YORK--(BUSINESS WIRE)-- PAVmed Inc. (Nasdaq:PAVM, PAVMZ), a highly differentiated, multi-product medical device company, today announced it has finalized a definitive licensing agreement with...
-
Apr 24, 2018PAVmed subsidiary to receive exclusive worldwide license to commercialize EsoCheck
NEW YORK--(BUSINESS WIRE)-- PAVmed Inc. (Nasdaq: PAVM, PAVMZ), a highly differentiated, multi-product medical device company, today announced that it has signed a letter of intent with Case...
-
Apr 11, 2018Conference call begins at 4:30 p.m. Eastern time today
NEW YORK--(BUSINESS WIRE)-- PAVmed Inc. (Nasdaq:PAVM, PAVMZ) (the “Company”), a highly differentiated, multiproduct medical device company, today reports financial results for the three and 12...
-
Apr 5, 2018
NEW YORK--(BUSINESS WIRE)-- PAVmed Inc. (Nasdaq: PAVM, PAVMW) (the “Company”), a highly differentiated, multiproduct medical device company, today announced the final results of its previously...
-
Apr 4, 2018
NEW YORK--(BUSINESS WIRE)-- PAVmed Inc. (Nasdaq: PAVM, PAVMW) (the “Company”), a highly differentiated, multiproduct medical device company, today announced that the Company will host a...
-
Apr 4, 2018
NEW YORK--(BUSINESS WIRE)-- PAVmed Inc. (Nasdaq: PAVM, PAVMW) (the “Company”), a highly differentiated, multiproduct medical device company, today announced the preliminary results of its...
-
Mar 16, 2018
NEW YORK--(BUSINESS WIRE)-- PAVmed Inc. (Nasdaq: PAVM, PAVMW) (the “Company”), a highly differentiated, multiproduct medical device company, today announced that its previously disclosed offer...
-
Mar 14, 2018
NEW YORK--(BUSINESS WIRE)-- PAVmed Inc. (Nasdaq: PAVM, PAVMW) (the “Company”), a highly differentiated, multiproduct medical device company, today announced that Lishan Aklog, M.D., PAVmed’s...
-
Feb 21, 2018Warrant Exchange Offer to Extend Until March 19, 2018
NEW YORK--(BUSINESS WIRE)-- PAVmed Inc. (Nasdaq: PAVM, PAVMW) (the “Company”), a highly differentiated, multiproduct medical device company, today announced the filing of a warrant exchange...
-
Feb 12, 2018New Warrants to be Identical to Those Issuable in Recently Announced Rights Offering
NEW YORK--(BUSINESS WIRE)-- PAVmed Inc. (Nasdaq: PAVM, PAVMW) (the “Company”), a highly differentiated, multiproduct medical device company, today announced it intends to file exchange offer...
-
Feb 9, 2018
NEW YORK--(BUSINESS WIRE)-- PAVmed Inc. (Nasdaq: PAVM, PAVMW) (“PAVmed”), a highly differentiated, multiproduct medical device company, today announced the completion of its previously...
-
Jan 25, 2018
NEW YORK--(BUSINESS WIRE)-- PAVmed Inc. (Nasdaq: PAVM, PAVMW) (“PAVmed”), a highly differentiated, multiproduct medical device company, today announced that it has completed the sale of...
-
Jan 23, 2018
NEW YORK--(BUSINESS WIRE)-- PAVmed Inc. (Nasdaq: PAVM, PAVMW) (“PAVmed”), a highly differentiated, multiproduct medical device company, today announced the closing of its previously announced...
-
Jan 19, 2018
NEW YORK--(BUSINESS WIRE)-- PAVmed Inc. (Nasdaq: PAVM, PAVMW) (“PAVmed”), a highly differentiated, multiproduct medical device company, today announced the pricing of its previously announced...
-
Jan 18, 2018
NEW YORK--(BUSINESS WIRE)-- PAVmed Inc. (Nasdaq: PAVM, PAVMW)) (“PAVmed”), a highly differentiated, multiproduct medical device company, today announced that it intends to offer shares of...
-
Jan 17, 2018Each Right Will Entitle Holder to Purchase One New Unit
NEW YORK--(BUSINESS WIRE)-- PAVmed Inc. (Nasdaq: PAVM, PAVMW) (the “Company”), a highly differentiated, multiproduct medical device company, today announced that the Company has set the terms...
-
Jan 11, 2018Tender Offer to Extend Until February 8, 2018
NEW YORK--(BUSINESS WIRE)-- PAVmed Inc. (Nasdaq: PAVM, PAVMW) (the “Company”), a highly differentiated, multiproduct medical device company, today announced the filing of a Tender Offer and...
-
Dec 28, 2017
NEW YORK--(BUSINESS WIRE)-- PAVmed Inc. (Nasdaq: PAVM, PAVMW) (the “Company”), a highly differentiated, multiproduct medical device company, today announced that it intends to temporarily...
Dec 18, 2017Device designed to replace invasive carpal tunnel surgery, addressing an estimated $1 billion market opportunityNEW YORK--(BUSINESS WIRE)-- PAVmed Inc. (Nasdaq: PAVM, PAVMW), a highly differentiated, multiproduct medical device company, today announced that CarpX™, its minimally invasive device designed...
-
Nov 28, 2017Designed to replace invasive surgery and shorten recovery time; addresses an estimated $1 billion market opportunity
NEW YORK--(BUSINESS WIRE)-- PAVmed Inc. (Nasdaq: PAVM, PAVMW), a highly differentiated, multiproduct medical device company, today announced that it has filed a 510(k) premarket notification...
-
Nov 15, 2017Conference call to be held November 16, 2017 at 4:30 p.m. Eastern time
NEW YORK--(BUSINESS WIRE)-- PAVmed Inc. (Nasdaq: PAVM, PAVMW), a highly differentiated, multiproduct medical device company, today announced financial results for the three and nine months ended...
-
Nov 9, 2017
NEW YORK--(BUSINESS WIRE)-- PAVmed Inc. (NASDAQ:PAVM; PAVMW), a highly differentiated, multi-product medical device company, today announced that the Company will host a conference call on...
-
Oct 10, 2017
NEW YORK--(BUSINESS WIRE)-- PAVmed Inc. (NASDAQ:PAVM; PAVMW), a highly differentiated, multi-product medical device company, today announced that Dennis McGrath, PAVmed’s Chief Financial...
-
Sep 18, 2017
NEW YORK--(BUSINESS WIRE)-- PAVmed Inc. (NASDAQ:PAVM; PAVMW), a highly differentiated, multi-product medical device company, today announced that Lishan Aklog, M.D., PAVmed’s Chairman and Chief...
-
Aug 14, 2017Conference call to be held August 17, 2017 at 4:30 p.m. Eastern time
NEW YORK--(BUSINESS WIRE)-- PAVmed Inc. (Nasdaq: PAVM, PAVMW), a highly differentiated, multiproduct medical device company, today announced financial results for the three and six months ended...
-
Aug 9, 2017
NEW YORK--(BUSINESS WIRE)-- PAVmed Inc. (NASDAQ:PAVM; PAVMW), a highly differentiated, multi-product medical device company, today announced that the Company will host a conference call on...
-
Jul 5, 2017
NEW YORK--(BUSINESS WIRE)-- PAVmed Inc. (Nasdaq:PAVM, PAVMW), a highly differentiated, multi-product medical device company, today announced the closing of a $5 million financing provided by...
-
Jun 23, 2017
NEW YORK--(BUSINESS WIRE)-- PAVmed Inc. (Nasdaq: PAVM, PAVMW), a highly differentiated, multiproduct medical device company, today announced that on June 23, 2017, the Securities and Exchange...
-
Jun 22, 2017
NEW YORK--(BUSINESS WIRE)-- PAVmed Inc. (Nasdaq: PAVM, PAVMW), a highly differentiated, multiproduct medical device company, today announced that the Company will join the Russell Microcap® Index...
-
May 22, 2017Conference call to be held May 31, 2017 at 4:30 p.m. Eastern time
NEW YORK--(BUSINESS WIRE)-- PAVmed Inc. (Nasdaq: PAVM, PAVMW), a highly differentiated, multiproduct medical device company, today announced financial results for the three months ended March 31,...
-
May 16, 2017
NEW YORK--(BUSINESS WIRE)-- PAVmed Inc. (NASDAQ:PAVM, PAVMW), a highly differentiated, multi-product medical device company, today announced that the Company will postpone its business update...
-
May 10, 2017
NEW YORK--(BUSINESS WIRE)-- PAVmed Inc. (NASDAQ:PAVM; PAVMW), a highly differentiated, multi-product medical device company, today announced that the Company will host a conference call on May 17,...
-
Apr 10, 2017Exchange Structured to Reward Current Security Holders and Incentivize Long-term Ownership by Both Existing and New Investors
NEW YORK--(BUSINESS WIRE)-- PAVmed Inc. (Nasdaq: PAVM, PAVMW), a highly differentiated, multi-product medical device company, today announced that it filed a registration statement on Form S-4...
-
Mar 31, 2017Company Presentation Set for April 4th at 12:50 p.m. ET
NEW YORK--(BUSINESS WIRE)-- PAVmed Inc. (Nasdaq:PAVM)(Nasdaq:PAVMW), a highly differentiated, multi-product medical device company, today announced a revised time for the Company’s presentation...
-
Mar 28, 2017No Securities Available for Resale Prior to Effectiveness and Nasdaq-related Approvals
NEW YORK--(BUSINESS WIRE)-- PAVmed Inc. (Nasdaq: PAVM, PAVMW), a highly differentiated, multi-product medical device company, today announced that the Company has filed a registration statement on...
-
Mar 28, 2017
NEW YORK--(BUSINESS WIRE)-- PAVmed Inc. (Nasdaq: PAVM, PAVMW), a highly differentiated, multi-product medical device company, today announced that Lishan Aklog, M.D., PAVmed’s Chairman and Chief...
-
Mar 21, 2017
NEW YORK--(BUSINESS WIRE)-- PAVmed Inc. (Nasdaq: PAVM, PAVMW), a highly differentiated, multi-product medical device company, today announced that it has appointed Dennis M. McGrath as its new...
-
Mar 9, 2017Aggregate Private Placement Proceeds Exceed $2.5 Million
NEW YORK--(BUSINESS WIRE)-- PAVmed Inc. (Nasdaq:PAVM, PAVMW), a highly differentiated, multi-product medical device company, today announced the closing of approximately $1.0 million in additional...
-
Feb 23, 2017Exchange to Provide Incentives for Long-Term Ownership by Existing and New Investors
NEW YORK--(BUSINESS WIRE)-- PAVmed Inc. (Nasdaq: PAVM, PAVMW) announced today that the Company intends to effectuate a registered exchange offer (the “Exchange”) whereby PAVmed’s Common...
-
Feb 17, 2017Fourth Quarter 2016 Financial Results Announced
NEW YORK--(BUSINESS WIRE)-- PAVmed Inc. (Nasdaq: PAVM,PAVMW), a highly differentiated, multi-product medical device company, today announced financial results for the fourth quarter and year ended...
-
Feb 3, 2017
NEW YORK--(BUSINESS WIRE)-- PAVmed Inc. (Nasdaq:PAVM,PAVMW), a highly differentiated, multi-product medical device company, announced that at 4:00 pm today the Securities and Exchange Commission...
-
Feb 2, 2017Company Considering Exchange Offers to Enhance Value of Outstanding Securities
NEW YORK--(BUSINESS WIRE)-- PAVmed Inc. (Nasdaq:PAVM, PAVMW), a highly differentiated, multi-product medical device company, today announced the closing of a $1.5 million financing. The private...
Dec 19, 2016First product regulatory submission marks major corporate milestoneNEW YORK--(BUSINESS WIRE)-- PAVmed Inc. (Nasdaq: PAVM,PAVMW), a highly differentiated, multi-product medical device company, today announced that it has filed a 510(k) premarket notification...
-
Dec 2, 2016- Third Quarter 2016 Financial Results Announced -
NEW YORK--(BUSINESS WIRE)-- PAVmed Inc. (Nasdaq:PAVM,PAVMW), a highly differentiated, multi-product medical device company, today announced financial results for the third quarter ended September...
-
Nov 10, 2016
NEW YORK--(BUSINESS WIRE)-- PAVmed Inc. (Nasdaq:PAVM), a highly differentiated, multi-product medical device company, today announced that Lishan Aklog, M.D., PAVmed’s Chairman and Chief...
-
Nov 4, 2016Agreement provides PAVmed with license to develop and commercialize antibiotic-eluting resorbable ear tube devices expected to benefit up to one million children per year
NEW YORK--(BUSINESS WIRE)-- PAVmed Inc. (Nasdaq: PAVM, PAVMW), a highly differentiated, multi-product medical device company, today announced that it has signed a definitive licensing agreement...